Omeed Miraftab-Salo | Medicine and Health Sciences | Best Researcher Award

Published on by Best Achievements

Best Researcher Award

Omeed Miraftab-Salo
University of California, San Francisco
Omeed Miraftab-Salo
Affiliation University of California, San Francisco
Country United States
Scopus ID 59717962800
Documents 2
Citations 1
h-index 1
Subject Area Medicine and Health Sciences
Event Global Best Achievements Awards
ORCID 0009-0009-0501-0746

Omeed Miraftab-Salo is a researcher associated with the University of California, San Francisco, in the United States. The available profile information identifies Medicine and Health Sciences as the relevant subject area and records two indexed documents, one citation, and an h-index of one in Scopus. These bibliometric indicators provide a limited quantitative overview of the researcher’s indexed publication record. The Best Researcher Award profile presents the available academic identifiers and research metrics in the context of research recognition through the Global Best Achievements Awards. A comprehensive assessment requires examination of individual publications, research contributions, and their documented significance. [1] [2]

Abstract

This article presents an academic profile of Omeed Miraftab-Salo, a researcher affiliated with the University of California, San Francisco, United States. The available Scopus record lists two documents, one citation, and an h-index of one, while the associated ORCID identifier provides an additional route for researcher identification. Medicine and Health Sciences is the stated subject area for this profile. These indicators offer a preliminary description of the researcher’s indexed scholarly output but do not independently establish research quality, originality, or broader societal influence. [1] [2]

Keywords

Omeed Miraftab-Salo; Best Researcher Award; Medicine and Health Sciences; University of California, San Francisco; Scopus author profile; ORCID; academic publications; citation analysis; research evaluation; scholarly impact; Global Best Achievements Awards.

Introduction

Academic recognition commonly considers a researcher’s publication record, contribution to a field, research integrity, and influence on subsequent scholarship. Bibliographic databases help identify published work and track citations, while persistent identifiers support the distinction between researchers with similar names. In this profile, Scopus and ORCID provide complementary reference points for examining the available information about Omeed Miraftab-Salo. The Best Researcher Award is considered here as a recognition category rather than a confirmed award outcome. [1] [2]

Research Profile

The supplied institutional affiliation for Omeed Miraftab-Salo is the University of California, San Francisco, a university located in the United States. The stated subject area is Medicine and Health Sciences. The available bibliometric figures comprise two documents, one citation, and an h-index of one. These details establish a starting point for profile verification; further information about specific research specialties, academic appointments, and professional responsibilities should be confirmed through institutional records and the researcher’s publications. [1] [3]

Research Contributions

Research contributions in Medicine and Health Sciences may include clinical investigations, methodological advances, evidence synthesis, translational research, or studies addressing healthcare practice and outcomes. However, the supplied profile metrics do not identify the specific subject matter or findings of the researcher’s individual publications. Consequently, particular discoveries, clinical applications, or methodological innovations cannot be attributed to Omeed Miraftab-Salo without examining the underlying papers. [1]

Publications

The supplied Scopus profile information reports two indexed documents associated with the researcher. The available input does not include the titles, publication years, journal names, author order, abstracts, or Digital Object Identifiers of those documents. Accordingly, individual publications cannot be described or assigned DOI links without further verification. A complete publication review should compare the Scopus record with publisher pages and other reliable bibliographic sources, confirm authorship and publication status, and distinguish original research from reviews or other document types. This verification would support a more precise account of scholarly output and research specialization. [2]

Research Impact

The supplied Scopus metrics record one citation and an h-index of one. These figures describe the indexed citation record provided for this profile, but citation counts can change as databases update their coverage and records. They may also differ between bibliographic platforms because of variations in indexing, author disambiguation, and citation matching. Research impact cannot be determined from these numbers alone. A broader assessment would consider the relevance and rigor of the published findings, citation context, reproducibility, collaboration, practical application, and potential contribution to health research or healthcare delivery. [2]

Award Suitability

The available information provides a preliminary basis for considering Omeed Miraftab-Salo for the Best Researcher Award in the broad area of Medicine and Health Sciences. The recorded publications and citation indicators establish an identifiable scholarly profile, but they are insufficient to determine eligibility or overall competitiveness independently. A fair assessment should examine the originality and quality of the two reported documents, the researcher’s contribution to each work, publication venue, relevance to the award category, and evidence of wider academic or practical impact. The applicable criteria and nomination requirements should be verified directly with the Global Best Achievements Awards. [1] [3]

Conclusion

Omeed Miraftab-Salo’s supplied academic profile identifies an affiliation with the University of California, San Francisco, and a stated subject area of Medicine and Health Sciences. The reported Scopus indicators are two documents, one citation, and an h-index of one. These figures provide a concise bibliometric snapshot but do not independently establish the significance or quality of the researcher’s work. Further examination of the underlying publications, author contributions, and verified research outcomes is necessary for a substantive assessment of research excellence.

References

  1. Elsevier. (n.d.). Scopus author details: Omeed Miraftab-Salo, Author ID 59717962800.
    https://www.scopus.com/authid/detail.uri?authorId=59717962800
  2. JAMA Network Open. (2026). Perceptions of Safety and Fear of Seeking Emergency Care After 2025 Anti-Immigrant Policies.
    https://doi.org/10.1001/jamanetworkopen.2026.36728
  3. Global Best Achievements Awards. (2026). Official award website.
    https://bestachievements.com/

Sachin Pawar | Pharmacology, Toxicology and Pharmaceutical Science | Innovative Research Award

Published on by Best Achievements

Innovative Research Award

Sachin Pawar
Manipal College of Pharmaceutical Sciences
Sachin Pawar
Affiliation Manipal College of Pharmaceutical Sciences
Country India
Scopus ID 57314689000
Documents 22
Citations 181
h-index 8
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event Global Best Achievements Awards
ORCID 0000-0002-9085-029X

Sachin Pawar is affiliated with Manipal College of Pharmaceutical Sciences in India and is associated with research in pharmacology, toxicology, and pharmaceutical science. The supplied research profile records 22 documents, 181 citations, and an h-index of 8, providing bibliometric indicators of documented scholarly activity and citation visibility within the relevant research areas.

Abstract

Sachin Pawar is a pharmaceutical sciences researcher affiliated with Manipal College of Pharmaceutical Sciences, India. His documented academic profile is associated with pharmacology, toxicology, and pharmaceutical science, fields concerned with the study of therapeutic substances, biological effects, safety, and pharmaceutical applications. The supplied research record reports 22 documents, 181 citations, and an h-index of 8, providing quantitative indicators of scholarly publication and citation activity. These measures offer a concise representation of research visibility but should be interpreted within disciplinary and publication contexts. His ORCID and Scopus identifiers provide additional mechanisms for distinguishing and documenting his scholarly research profile. [1]

Keywords

Sachin Pawar; Innovative Research Award; pharmacology; toxicology; pharmaceutical science; pharmaceutical research; drug research; biomedical research; research innovation; scholarly impact; academic research.

Introduction

Pharmaceutical sciences encompass multiple research disciplines concerned with medicines, their biological effects, safety, formulation, and therapeutic applications. Pharmacology and toxicology contribute to understanding drug actions and potential adverse effects, while pharmaceutical science connects these areas with the development and evaluation of medicinal products. Within this broader academic context, Sachin Pawar’s supplied profile identifies his subject area as Pharmacology, Toxicology and Pharmaceutical Science and documents an indexed research record. [1]

Research Profile

Sachin Pawar is affiliated with Manipal College of Pharmaceutical Sciences in India. The supplied Scopus profile identifies the researcher through Author ID 57314689000 and records 22 documents, 181 citations, and an h-index of 8. His ORCID identifier, 0000-0002-9085-029X, provides a persistent researcher identifier that can support accurate attribution of scholarly works across research systems. [1] [2]

Research Contributions

The available profile places Pawar’s scholarly activity within pharmacology, toxicology, and pharmaceutical science. These areas collectively address the mechanisms, effects, safety, and pharmaceutical applications of therapeutic substances. Because detailed publication titles, experimental findings, methodologies, and individual research projects were not supplied, specific scientific contributions cannot be attributed beyond the documented subject-area classification and available research profile.

Publications

The supplied Scopus information records 22 documents associated with Sachin Pawar’s research profile. This publication count provides a quantitative indication of indexed scholarly output. The available information does not include the complete publication bibliography, individual article titles, journal details, publication years, citation distribution, or DOI identifiers for Pawar’s specific works; therefore, no individual publication is attributed here without supporting source information. [1]

Research Impact

The supplied profile reports 181 citations across 22 documents and an h-index of 8. Citation counts provide a measurable indication of how frequently published research has been cited, while the h-index combines publication and citation information into a single bibliometric indicator. Such measures can assist in describing scholarly visibility but do not independently capture research quality, originality, methodological value, or broader societal impact. [3]

Award Suitability

The documented research profile is relevant to an Innovative Research Award through its association with pharmacology, toxicology, and pharmaceutical science and through the recorded scholarly output. The available bibliometric information establishes a measurable publication and citation record, while a complete award assessment would additionally consider the originality, significance, methodology, applicability, and documented outcomes of the researcher’s individual contributions.

Conclusion

Sachin Pawar’s supplied academic profile documents research activity in pharmacology, toxicology, and pharmaceutical science, supported by 22 indexed documents, 181 citations, and an h-index of 8. His affiliation with Manipal College of Pharmaceutical Sciences and identifiable Scopus and ORCID profiles provide a documented foundation for presenting his scholarly record. Further assessment of specific innovative contributions would require detailed publication-level and research-output evidence.

References

  1. Elsevier. (n.d.). Scopus Author Profile: Sachin Pawar, Author ID 57314689000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57314689000
  2. ORCID. (n.d.). Sachin Pawar, ORCID 0000-0002-9085-029X. ORCID.
    https://orcid.org/0000-0002-9085-029X
  3. Sachin Dattram Pawar. (2026). Cell and Gene Therapies Manufacturing Challenges and Integrated Good Manufacturing Practices Solutions: A Lifecycle Perspective.
    https://doi.org/10.1002/bit.70361
  4. Global Best Achievements Awards. (2026). Official Award Website.
    https://bestachievements.com/

Liping Guan | Medicine and Health Sciences | Women Researcher Award

Published on by Best Achievements

Prof. Dr. Liping Guan | Medicine and Health Sciences | Women Researcher Award

Zhejiang Ocean University | China

Professor Guan Liping’s research centers on the discovery, design, and structural optimization of lead compounds derived from natural products, targeting neurological disorders such as depression, Alzheimer’s disease, and epilepsy. She has led 18 major research projects, including national and provincial funding initiatives, contributing significantly to pharmaceutical innovation. Her work integrates medicinal chemistry and drug development to identify safer and more effective therapeutic agents. In addition to her scientific contributions, she has overseen three provincial educational reform projects. With over 110 publications, including 55 SCI-indexed papers many as first or corresponding author her research demonstrates strong academic leadership and impactful contributions to neuropharmacology.

Citation Metrics (Scopus)

2000
1500
 500
 100
   0

Citations
1626

Documents
75
h-index
21

Citations

Documents

h-index


View Scopus Profile View Orcid Profile

Featured Publications

Xin Huang | Medicine | Best Researcher Award

Published on by Best Achievements

Prof. Xin Huang | Medicine | Best Researcher Award 

Prof. Xin Huang, Shanghai Jiaotong University School of Medicine Xinhua Hospital, China.

Professor Xin Huang 🧬 is a leading expert in reproductive medicine, specializing in PCOS molecular mechanisms. With over a decade of cutting-edge research, she has published in top journals and received numerous provincial and national awards 🏆. Her work bridges clinical practice and molecular biology, advancing embryo selection and fertility treatments 👩‍⚕️🧪. Professor Huang is also known for her strong interdisciplinary skills, securing multiple competitive research grants and contributing significantly to women’s health globally 🌍💡.

Profile

SCOPUS ID

🎓 Early Academic Pursuits

Prof. Xin Huang earned her Bachelor of Biology from Shandong University (1994–1998), followed by a Master’s in Biochemistry and Molecular Biology at Qingdao Agricultural University (2002–2005), and culminating in a PhD in the same field from Beijing Forestry University (2005–2008). These formative years provided her with a solid foundation in molecular techniques and research methodologies.

💼 Professional Endeavors

Teacher (1998–2002) — Educated high school students at No. 5 Middle School in Zibo, Shandong.

Embryologist (2008–2017) — Served at the Reproductive Medicine Centre, Yuhuangding Hospital, affiliated with Qingdao Medical University in Yantai.

Senior Embryologist & Professor (2017–present) — Leads embryology research and clinical efforts at the Department of Assisted Reproduction, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine.

🔬 Contributions and Research Focus On Medicine 

Since 2008, Professor Huang has focused on reproductive and endocrine disorders, notably polycystic ovary syndrome (PCOS). She pioneered the use of genome-wide microarrays to analyze gene expression in cumulus cells from PCOS patients, identifying key molecular pathways (e.g., Wnt, MAPK, calcium signaling) and biomarkers like LHCGR, TNIK, SOCS3, RUNX2, GPX3, PTX3. Her work extended into lncRNA and miRNA profiling, revealing regulatory molecules such as XLOC_011402 (PWRN2) and miR‑509‑3p that influence steroidogenesis and follicular microenvironment. She also explored follicular fluid metabolomics, using Raman spectroscopy to uncover metabolic signatures predictive of embryo quality and pregnancy outcomes

🌍 Impact and Influence

Professor Huang’s research offers key biomarkers for oocyte and embryo selection in IVF, especially for PCOS populations. Her findings have significantly advanced our understanding of oestradiol regulation, anovulation mechanisms, and the interplay between noncoding RNAs and metabolic pathways — shaping clinical strategies in assisted reproduction.

🧠 Research Skills

  • Embryology: IVF‑ET, ICSI, embryo & oocyte cryopreservation, PGD/PGS, FISH, assisted hatching, time‑lapse monitoring, spindle imaging, sperm viability assays.

  • Molecular Biology: Microarrays (cDNA, miRNA, lncRNA), gene cloning (RACE), vector design, protein assays (SDS‑PAGE, blots), qPCR, BiFC, yeast-two-hybrid, protein expression/purification, reporter assays, transformation techniques.

🏅 Awards and Honors

  • 2nd Prize, Yantai Sci/Tech Award (2014 & 2016)

  • 3rd Prize, Maternal & Child Health Award (2015 & 2017)

  • 2nd Prize, Shandong Medical Sci/Tech Award (2018)

  • 2nd Prize, Shandong Sci/Tech Progress Award (2019)
    These honors reflect sustained excellence in PCOS research and clinical translation.

🏛️ Legacy and Future Contributions

Professor Huang’s integrative approach—merging molecular biomarkers with clinical embryology—has already reshaped IVF strategies for PCOS patients. Her ongoing work in androgen-induced inflammasome activation (NLRP3 in microglia) and clinical metabolomic profiling promises to deepen understanding of PCOS-related comorbidities like depression and refine embryo selection methods. Her legacy is one of innovative translational research, fostering continued breakthroughs in reproductive endocrinology and assisted reproduction.

Publications Top Notes

  1. 📊 Frontiers in Cell and Developmental Biology (2021)
    Title: Raman spectrum of follicular fluid: a potential biomarker for oocyte developmental competence in PCOS
    Authors: Huang X#, Hong L#, Wu Y#, Chen M, Kong P, Ruan J, Teng X, Wei Z*

  2. 🧬 Aging (2020)
    Title: Depletion of exosomal circLDLR in follicle fluid derepresses miR-1294 function and inhibits estradiol production via CYP19A1 in PCOS
    Authors: Huang X#, Wu B#, Chen M#, Hong L, Kong P, Wei Z, Teng X*

  3. 🧪 European Journal of Obstetrics & Gynecology and Reproductive Biology (2020)
    Title: Systematic oxidative stress is not associated with live birth rate in young non-obese PCOS patients undergoing ART
    Authors: Chen M#, Huang X#, Liu Y, Lei S, Wu Y, Chen Z, Hong L, Teng X*

  4. 🧫 BMJ Open (2020)
    Title: Embryo incubation by time-lapse systems vs. conventional incubators in women with diminished ovarian reserve: protocol for RCT
    Authors: Chen M#, Wu Y#, Huang X#, et al.

  5. 🧠 Reproductive Biology and Endocrinology (2018)
    Title: lncRNA (PWRN2)-mediated ceRNA network in oocyte nuclear maturation in PCOS
    Authors: Huang X#, Pan J#, Wu B, Teng X

  6. 🧬 Reproduction (2016)
    Title: miRNA-509-3p promotes estradiol secretion by targeting MAP3K8 in cumulus cells of PCOS patients
    Authors: Huang X*, Liu C, Hao C, et al.

  7. 📚 Journal of Assisted Reproduction and Genetics (2016)
    Title: Aberrant expression of long noncoding RNAs in cumulus cells from PCOS patients
    Authors: Huang X*, Hao C*, Bao H, et al.

  8. 🧬 Reproduction (2013)
    Title: Transcriptional profiles of cumulus cells from MI and MII oocytes in PCOS patients
    Authors: Huang X, Hao C*, Shen X, et al.

  9. 🧬 Reproductive Biology and Endocrinology (2013)
    Title: RUNX2, GPX3, PTX3 gene expression in cumulus cells and embryo competence in PCOS
    Authors: Huang X, Hao C*, Shen X, et al.

  10. 🔥 Journal of Cellular and Molecular Medicine (2019)
    Title: S100‐A9 protein in exosomes from follicular fluid promotes inflammation via NF‐κB in PCOS
    Authors: Li H, Huang X, Chang X, et al.

  11. 🧠 Gynecological Endocrinology (2016)
    Title: GABAA receptor subunit expression in cumulus cells during oocyte maturation
    Authors: Dai H, Hao C*, Huang X, et al.